These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 27710803)

  • 1. Clinical outcome of statin plus ezetimibe versus high-intensity statin therapy in patients with acute myocardial infarction propensity-score matching analysis.
    Ji MS; Jeong MH; Ahn YK; Kim SH; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Int J Cardiol; 2016 Dec; 225():50-59. PubMed ID: 27710803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study.
    Chang SH; Wu LS; Lee CH; Kuo CT; Liu JR; Wen MS; Chen WJ; See LC; Yeh YH
    Int J Cardiol; 2015; 190():20-5. PubMed ID: 25912112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of low- or moderate-intensity statin and ezetimibe vs. high-intensity statin monotherapy on primary prevention of cardiovascular disease and all-cause death: a propensity-matched nationwide cohort study.
    Jun JE; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Eur J Prev Cardiol; 2024 Aug; 31(10):1205-1213. PubMed ID: 38408362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity Statin Monotherapy in Type 2 Diabetes.
    Park SY; Jun JE; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1883-1890. PubMed ID: 38175670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.
    Murphy SA; Cannon CP; Blazing MA; Giugliano RP; White JA; Lokhnygina Y; Reist C; Im K; Bohula EA; Isaza D; Lopez-Sendon J; Dellborg M; Kher U; Tershakovec AM; Braunwald E
    J Am Coll Cardiol; 2016 Feb; 67(4):353-361. PubMed ID: 26821621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study.
    Pauriah M; Elder DH; Ogston S; Noman AY; Majeed A; Wyatt JC; Choy AM; Macdonald TM; Struthers AD; Lang CC
    Heart; 2014 Jun; 100(11):867-72. PubMed ID: 24553389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
    Lancellotti P; Pierard LA; Scheen AJ
    Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent prognostic effect of high sensitivity C-reactive protein with statin therapy in acute myocardial infarction.
    Kang DO; Park Y; Seo JH; Jeong MH; Chae SC; Ahn TH; Jang WY; Kim W; Park EJ; Choi BG; Na JO; Choi CU; Kim EJ; Rha SW; Park CG; Seo HS;
    J Cardiol; 2019 Jul; 74(1):74-83. PubMed ID: 30745001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Statin Therapy on Clinical Outcomes of Survivors of Acute Myocardial Infarction with Severe Systolic Heart Failure.
    Woo JS; Hwang SJ; Kim HS; Kim JB; Kim WS; Kim KS; Jeong MH; Kim W;
    PLoS One; 2015; 10(12):e0144602. PubMed ID: 26658751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
    Bohula EA; Giugliano RP; Cannon CP; Zhou J; Murphy SA; White JA; Tershakovec AM; Blazing MA; Braunwald E
    Circulation; 2015 Sep; 132(13):1224-33. PubMed ID: 26330412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Statin Intensity on Clinical Outcome in Acute Myocardial Infarction Patients.
    Hwang D; Kim HK; Lee JM; Choi KH; Kim J; Rhee TM; Park J; Park TK; Yang JH; Song YB; Choi JH; Hahn JY; Choi SH; Koo BK; Kim YJ; Chae SC; Cho MC; Kim CJ; Gwon HC; Jeong MH; Kim HS;
    Circ J; 2018 Mar; 82(4):1112-1120. PubMed ID: 29491327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a combination of ezetimibe and statins in patients with acute coronary syndrome and multiple comorbidities: A 6-year population-based cohort study.
    Lin Wu FL; Wang J; Ho W; Chou CH; Wu YJ; Choo DW; Wang YW; Chen PY; Chien KL; Lin ZF
    Int J Cardiol; 2017 Apr; 233():43-51. PubMed ID: 28190615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in Patients With a History of Acute Coronary Syndrome: Analysis of Results of the IMPROVE-IT Trial.
    Almalki ZS; Guo JJ; Alahmari A; Alotaibi N; Thaibah H
    Heart Lung Circ; 2018 Jun; 27(6):656-665. PubMed ID: 28716519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute Myocardial Infarction (BATTLE-AMI) study: study protocol for a randomized controlled trial.
    Fonseca FAH; Izar MC; Maugeri IML; Berwanger O; Damiani LP; Pinto IM; Szarf G; França CN; Bianco HT; Moreira FT; Caixeta A; Alves CMR; Soriano Lopes A; Klassen A; Tavares MFM; Fonseca HA; Carvalho ACC;
    Trials; 2017 Dec; 18(1):601. PubMed ID: 29258572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of postdischarge statin withdrawal on long-term outcomes in patients with acute myocardial infarction.
    Kim MC; Cho JY; Jeong HC; Lee KH; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Seung KB; Chang K; Ahn Y
    Am J Cardiol; 2015 Jan; 115(1):1-7. PubMed ID: 25456863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl.
    Piao ZH; Jin L; Kim JH; Ahn Y; Kim YJ; Cho MC; Kim CJ; Kim HS; Liu B; Jeong MH;
    Am J Cardiol; 2017 Jul; 120(2):174-180. PubMed ID: 28532771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute Myocardial Infarction Registry.
    Kim YH; Her AY; Jeong MH; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1264-1275. PubMed ID: 30474346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study.
    Lee YH; Hong N; Lee CJ; Park SH; Lee BW; Cha BS; Kang ES
    Sci Rep; 2018 Aug; 8(1):11925. PubMed ID: 30093717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
    Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial Effect of Statin Therapy at a High Dose Versus Low Dose Associated with Ezetimibe.
    Garcia MM; Varela CG; Silva PF; Lima PR; Góes PM; Rodrigues MG; Silva Mde L; Ladeia AM; Guimarães AC; Correia LC
    Arq Bras Cardiol; 2016 Apr; 106(4):279-88. PubMed ID: 27142792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.